Core Scientific Inc vs JPMorgan Chase & Co — how do they compare? Core Scientific Inc trades at $22.34 (market cap $7.02B), while JPMorgan Chase & Co trades at $346.92 (market cap $911.47B). The key difference: JPMorgan Chase & Co is far larger — about 129.8× Core Scientific Inc's market cap, and JPMorgan Chase & Co pays a 1.75% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.
| CORZ | JPM | |
|---|---|---|
Market Cap | $7.02B | $911.47B |
Sector | Technology | Financials |
52-Week High | $29.16 | $342.89 |
52-Week Low | $12.65 | $282.84 |
Enterprise Value | $8.07B | — |
Volume | — | 10,479,943 |
Dividend Yield | — | 1.75% |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $22.71, down 3.32% today, with a bearish technical signal despite strong analyst support. The company is transitioning from Bitcoin mining to AI colocation, with Q1 2026 colocation revenue surging to $77.5M and gross margins of 57%. However, the company continues to report significant losses with a net income margin of -341.68% and negative cash flow of $525.6M in 2025.
The outlook remains speculative with substantial execution risk despite analyst optimism. While the AI pivot offers growth potential, persistent losses and cash burn present significant challenges. The consensus price target of $34.17 suggests 50% upside potential, but investors must weigh the high-risk transformation against the company's current financial instability.
JPMorgan Chase (JPM) trades at $347.22, up 3.79% on the day, with a bullish technical outlook and strong institutional support. The stock shows robust fundamentals with a 31.61% net income margin and 17.03% ROE, though Q4 2025 EPS missed expectations. Recent news highlights CEO Jamie Dimon's economic warnings and upcoming Q1 2026 earnings, with analysts projecting a consensus price target of $377.75. Cash flow trends indicate significant investing outflows balanced by financing inflows.
JPM offers a solid investment case with attractive valuation (P/E 14.69) and analyst consensus leaning buy (51.67%), but risks include geopolitical tensions, cybersecurity threats, and volatile cash flows. The stock's proximity to its 52-week high suggests limited near-term upside, requiring careful monitoring of Q1 earnings results and macroeconomic indicators.
Trailing returns across standard periods
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →